A bipartisan group of senators and congressional representatives reintroduced the Patent Eligibility Restoration Act (PERA), which aims to reform the law of patent eligibility under 35 U.S.C. § 101. PERA seeks to address the challenges posed by recent …

The May 1 reintroduction of two bills designed to strengthen the certainty of U.S. patents earned praise from the Biotechnology Innovation Organization (BIO). The Patent Eligibility Restoration Act (PERA Act) would address confusing court decisions by …

… on calls for pharmaceutical patent reform for a while. … nonprofit organization that advocates drug patent reform, says that “excessive” … pharmaceutical industry maintains that patent reform isn’t needed. It … on two bipartisan drug patent reform bills in the …

… of USPTO Director Vidal, pharmaceutical patent reform is likely on the minds … to this political transition, pharmaceutical patent reform garnered renewed attention in the …

Coke Stewart. Photo credit: USPTO As a patent lawyer, Coke Morgan Stewart has mainly represented patent challengers and has previously sat down with IAM to discuss her views on Section 101 and discretionary denials Register for limited access Register to …

This post has been updated since its original publication date. On November 15, 2024, the US Senate Judiciary Subcommittee on Intellectual Property advanced the Inventor Diversity for Economic Advancement (IDEA) Act, one of three significant bills it …

On November 15, 2024, the US Senate Judiciary Subcommittee on Intellectual Property advanced the Inventor Diversity for Economic Advancement (IDEA) Act, one of three significant bills it considered this year to reform the patent system. The other two bills …

Senate Judiciary Committee Chairman Dick Durbin Senators are wrangling behind the scenes over amendments to legislation to reform patent eligibility law and repair abuses in the Patent Trial and Appeal Board Register for limited access Register to receive …

… timelines. Comprehensive patent reform The report advocates that comprehensive patent reform is a viable …

While much of political life in the US is polarised, lawmakers and the executive branch have coalesced to find common ground in the fight against perceived disproportionately-high drug prices in the country. A variety of approaches have been deployed in an …